CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
August 20, 2020 01:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and HAMBURG, Germany and BERLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that...
CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport
August 19, 2020 02:00 ET
|
CENTOGENE GmbH
CENTOGENE expands its SARS-CoV-2 testing solution to Hamburg Airport after successfully launching the first walk-in COVID-19 test facility at Frankfurt Airport in June 2020 in cooperation with...
CentoMD® Update Reveals Further Insights Into Rare Diseases
August 11, 2020 06:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and...
CENTOGENE Supports Tajikistan in Fight Against the COVID-19 Pandemic
August 04, 2020 06:30 ET
|
CENTOGENE GmbH
CENTOGENE expands ongoing development cooperation with Ministry of Health and Social Protection of the Population of Tajikistan (MoH) to now include COVID-19 testingThe project supports access to...
CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs
July 27, 2020 08:00 ET
|
CENTOGENE GmbH
The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product...
CENTOGENE Announces Convenient At-Home Coronavirus Test Solution Now Available in Germany on Online Marketplace
July 23, 2020 02:30 ET
|
CENTOGENE GmbH
CENTOGENE announces test kits for the detection of SARS-CoV-2 virus RNA now available on Amazon in Germany ─ the first of its type offered on the online marketplaceOffering includes delivery of a...
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
July 09, 2020 19:19 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases...
CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19
July 09, 2020 06:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that...
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 07, 2020 18:16 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Announces Partnership with OESIS Network for COVID-19 PCR Testing for US School Populations
July 06, 2020 06:30 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and SANTA MONICA, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an...